LIMN
Liminatus Pharma, Inc.
$0.12
-0.01 (-5.02%)
At close · Jul 8
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“management has concluded that there is substantial doubt about its ability to continue as a going concern for one year after the date that the accompanying unaudited condensed consolidated financial statements are issued.”View the 10-Q filed May 15, 2026
Market Cap
$5.52M
Shares
44,877,633
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
-$10.21M
-187.8%
FY2025
Diluted EPS
-$0.43
-115%
FY2025
Operating Cash Flow
-$9.96M
-586.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 |
|---|---|---|---|
| — | — | $2.69M | |
| $3.4M | $2.97M | $644.62K | |
| $3.8M | $2.97M | $3.33M | |
| -$3.8M | -$2.97M | -$3.33M | |
| $119.03K | $215.9K | $338.88K | |
| — | $76.59K | $122.53K | |
| -$7.2M | -$7.24M | -$216.36K | |
| -$11M | -$10.21M | -$3.55M | |
| USD/shares | — | -$0.43 | -$0.20 |
| USD/shares | — | -$0.43 | -$0.20 |
| shares | — | 23.75M | 17.5M |
| shares | — | 23.75M | 17.5M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Key facts
CIK
1971387
CUSIP
53271X108
13F (30d)
1 filings
1 filers